HighTower Advisors’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-161
Closed -$4K 3919
2023
Q3
$4K Sell
161
-1,050
-87% -$86.3K ﹤0.01% 3437
2023
Q2
$169K Buy
1,211
+1,000
+474% +$128K ﹤0.01% 2931
2023
Q1
$18K Sell
211
-20
-9% -$2.71K ﹤0.01% 3157
2022
Q4
$33K Buy
231
+23
+11% +$7.79K ﹤0.01% 3083
2022
Q3
$180K Buy
208
+7
+3% +$4.39K ﹤0.01% 2634
2022
Q2
$88K Hold
201
﹤0.01% 2816
2022
Q1
$129K Buy
+201
New +$127K ﹤0.01% 2939

Other funds holding CANO

HighTower Advisors's CANO Position: Q4 2023 in Review

HighTower Advisors sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 161 shares — an estimated $4K sold.

HighTower Advisors first reported a position in CANO in Q1 2022 and held it in 7 quarters. The position peaked at $180K in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • HighTower Advisors reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • HighTower Advisors sold 161 Cano Health, Inc. shares in Q4 2023, an estimated $4K.
  • HighTower Advisors first reported a position in Cano Health, Inc. in Q1 2022 and held it in 7 quarters.
  • HighTower Advisors's Cano Health, Inc. position peaked at $180K in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on HighTower Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.